Confirmation of Results and Investor Presentation

 

 

15 November 2022

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

 

Confirmation of Interim Results

Investor Presentation

 

Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, confirms it will announce its interim results for the six months to 30 September 2022 on 24 November 2022.

 

Investor presentation

Jag Grewal, Chief Executive Officer, and Chris Lea, Chief Financial Officer, will provide a live presentation relating to the Company's Interim Results via the Investor Meet Company platform on 24 November 2022 at 4:30pm GMT.

 

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet Omega Diagnostics Group Plc via:

 

https://www.investormeetcompany.com/omega-diagnostics-group-plc/register-investor

 

Investors who already follow Omega Diagnostics Group Plc on the Investor Meet Company platform will automatically be invited.

 

Contacts: 

Omega Diagnostics Group PLC		www.omegadx.com
Jag Grewal, Chief Executive Officer		via Walbrook PR
Chris Lea, Chief Financial Officer
finnCap Ltd		Tel: 020 7220 0500
Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)
Alice Lane/Charlotte Sutcliffe (ECM)
Walbrook PR Limited	Tel: 020 7933 8780 or   omega@walbrookpr.com
Paul McManus	Mob: 07980 541 893
Lianne Applegarth	Mob: 07584 391 303
Sam Allen	Mob: 07502 558 258

 

About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition .

www.omegadx.com